AstraZeneca Pauses Vaccine Trial for Safety Review
The pharmaceutical company AstraZeneca halted large, late-stage global trials of its coronavirus vaccine on Tuesday because of a serious suspected adverse reaction in a participant, the company said. It is not yet known whether the reaction was directly caused by the company’s vaccine or was coincidental. The pause, which was first reported by STAT, will…
Details